1. Home
  2. ELDN vs CBFV Comparison

ELDN vs CBFV Comparison

Compare ELDN & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • CBFV
  • Stock Information
  • Founded
  • ELDN 2004
  • CBFV 1901
  • Country
  • ELDN United States
  • CBFV United States
  • Employees
  • ELDN N/A
  • CBFV N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • CBFV Major Banks
  • Sector
  • ELDN Health Care
  • CBFV Finance
  • Exchange
  • ELDN Nasdaq
  • CBFV Nasdaq
  • Market Cap
  • ELDN 178.4M
  • CBFV 143.6M
  • IPO Year
  • ELDN N/A
  • CBFV N/A
  • Fundamental
  • Price
  • ELDN $2.72
  • CBFV $27.49
  • Analyst Decision
  • ELDN Strong Buy
  • CBFV Hold
  • Analyst Count
  • ELDN 2
  • CBFV 2
  • Target Price
  • ELDN $12.50
  • CBFV $26.00
  • AVG Volume (30 Days)
  • ELDN 205.3K
  • CBFV 14.3K
  • Earning Date
  • ELDN 08-18-2025
  • CBFV 07-23-2025
  • Dividend Yield
  • ELDN N/A
  • CBFV 3.64%
  • EPS Growth
  • ELDN N/A
  • CBFV N/A
  • EPS
  • ELDN N/A
  • CBFV 1.92
  • Revenue
  • ELDN N/A
  • CBFV $49,545,000.00
  • Revenue This Year
  • ELDN N/A
  • CBFV $5.97
  • Revenue Next Year
  • ELDN N/A
  • CBFV $9.49
  • P/E Ratio
  • ELDN N/A
  • CBFV $14.34
  • Revenue Growth
  • ELDN N/A
  • CBFV N/A
  • 52 Week Low
  • ELDN $2.30
  • CBFV $20.75
  • 52 Week High
  • ELDN $5.54
  • CBFV $33.72
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 35.43
  • CBFV 31.68
  • Support Level
  • ELDN $2.76
  • CBFV $28.28
  • Resistance Level
  • ELDN $2.90
  • CBFV $28.04
  • Average True Range (ATR)
  • ELDN 0.16
  • CBFV 0.40
  • MACD
  • ELDN -0.03
  • CBFV -0.14
  • Stochastic Oscillator
  • ELDN 4.39
  • CBFV 16.44

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About CBFV CB Financial Services Inc.

CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.

Share on Social Networks: